Roche's ($RHHBY) Genentech unit launched a new late-stage trial testing a two-drug combo in melanoma patients, throwing its hat in the ring with GlaxoSmithKline ($GSK), which is testing a rival combo therapy. Report
USP <232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures are close to being adopted. But the monographs will not provide specific sample preparation methods. This article outlines three case studies for sample preparation. Download Today.
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 100,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!